These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16835796)

  • 1. Cytochrome P2A13 and P1A1 gene polymorphisms are associated with the occurrence of uterine leiomyoma.
    Herr D; Bettendorf H; Denschlag D; Keck C; Pietrowski D
    Arch Gynecol Obstet; 2006 Oct; 274(6):367-71. PubMed ID: 16835796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is genetic polymorphism of ER-α, CYP1A1, and CYP1B1 a risk factor for uterine leiomyoma?
    El-Shennawy GA; Elbialy AA; Isamil AE; El Behery MM
    Arch Gynecol Obstet; 2011 Jun; 283(6):1313-8. PubMed ID: 20559649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP1A1 and CYP1B1 genetic polymorphisms and uterine leiomyoma risk in Chinese women.
    Ye Y; Cheng X; Luo HB; Liu L; Li YB; Hou YP
    J Assist Reprod Genet; 2008 Aug; 25(8):389-94. PubMed ID: 18763031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism of the p53 tumor suppressor gene is associated with susceptibility to uterine leiomyoma.
    Denschlag D; Bettendorf H; Watermann D; Keck C; Tempfer C; Pietrowski D
    Fertil Steril; 2005 Jul; 84(1):162-6. PubMed ID: 16009172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination effect of cytochrome P450 1A1 gene polymorphisms on uterine leiomyoma: A case-control study.
    Salimi S; Sajadian M; Khodamian M; Yazdi A; Rezaee S; Mohammadpour-Gharehbagh A; Mokhtari M; Yaghmaie M
    Bosn J Basic Med Sci; 2016 Aug; 16(3):209-14. PubMed ID: 27333216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population.
    Gaikovitch EA; Cascorbi I; Mrozikiewicz PM; Brockmöller J; Frötschl R; Köpke K; Gerloff T; Chernov JN; Roots I
    Eur J Clin Pharmacol; 2003 Aug; 59(4):303-12. PubMed ID: 12879168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype distribution of estrogen receptor-alpha, catechol-O-methyltransferase, and cytochrome P450 17 gene polymorphisms in Caucasian women with uterine leiomyomas.
    Denschlag D; Bentz EK; Hefler L; Pietrowski D; Zeillinger R; Tempfer C; Tong D
    Fertil Steril; 2006 Feb; 85(2):462-7. PubMed ID: 16595228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association study between catechol-O-methyltransferase polymorphisms and uterine leiomyomas in a Japanese population.
    Morikawa J; Yoshida S; Kennedy S; Takemura N; Sugimoto M; Kitao K; Deguchi M; Ohara N; Maruo T
    Clin Exp Obstet Gynecol; 2008; 35(1):35-40. PubMed ID: 18390078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of MSP I CYP1A1 gene polymorphism in the development of uterine fibroids.
    Barão MA; Oliveira E; Gomes MT; da Silva ID; Sartori MG; Girão MJ; Castro Rde A
    Fertil Steril; 2010 Dec; 94(7):2783-5. PubMed ID: 20579990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in genes HSD17B1 and HSD17B2 and uterine leiomyoma risk in Chinese women.
    Cong RJ; Huang ZY; Cong L; Ye Y; Wang Z; Zha L; Cao LP; Su XW; Yan J; Li YB
    Arch Gynecol Obstet; 2012 Sep; 286(3):701-5. PubMed ID: 22546946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The -2549 insertion/deletion polymorphism of VEGF gene associated with uterine leiomyoma susceptibility in women from Southeastern Iran.
    Keshavarzi F; Salimi S; Mohammadpour-Gharehbagh A; Teimoori B; Yazdi A; Farajian-Mashhadi F; Yaghmaei M; Mokhtari M
    Ginekol Pol; 2017; 88(3):115-119. PubMed ID: 28397198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the CYP17 gene polymorphism with risk for uterine leiomyoma in Brazilian women.
    Vieira LC; Gomes MT; Castro Rde A; de Souza NC; da Silva ID; Baracat EC; Girão MJ
    Gynecol Endocrinol; 2008 Jul; 24(7):373-7. PubMed ID: 18645709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer.
    Suzuki S; Muroishi Y; Nakanishi I; Oda Y
    J Gastroenterol; 2004; 39(3):220-30. PubMed ID: 15064998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor alpha polymorphism and susceptibility to uterine leiomyoma.
    Villanova FE; Andrade PM; Otsuka AY; Gomes MT; Leal ES; Castro RA; Girão MJ; Nishimura E; Baracat EC; Silva ID
    Steroids; 2006 Nov; 71(11-12):960-5. PubMed ID: 16935316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allele and genotype frequencies of the polymorphic cytochrome P450 genes (CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19) in the Jordanian population.
    Yousef AM; Bulatova NR; Newman W; Hakooz N; Ismail S; Qusa H; Zahran F; Anwar Ababneh N; Hasan F; Zaloom I; Khayat G; Al-Zmili R; Naffa R; Al-Diab O
    Mol Biol Rep; 2012 Oct; 39(10):9423-33. PubMed ID: 22722998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP1A1, CYP3A5 and CYP3A7 polymorphisms and testicular cancer susceptibility.
    Kristiansen W; Haugen TB; Witczak O; Andersen JM; Fosså SD; Aschim EL
    Int J Androl; 2011 Feb; 34(1):77-83. PubMed ID: 20345875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms in the cytochrome P450 1A1 and 2E1 genes, smoking, drinking and prostate cancer susceptibility: a case-control study in a Han nationality population in Southern China.
    Yang J; Qian LX; Wu HF; Xu ZQ; Sui YG; Wang XR; Zhang W
    Int J Urol; 2006 Jun; 13(6):773-80. PubMed ID: 16834659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G-protein-coupled estrogen receptor-30 gene polymorphisms are associated with uterine leiomyoma risk.
    Kasap B; Öztürk Turhan N; Edgünlü T; Duran M; Akbaba E; Öner G
    Bosn J Basic Med Sci; 2016 Jan; 16(1):39-45. PubMed ID: 26773178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional evaluation of novel single nucleotide polymorphisms and haplotypes in the promoter regions of CYP1B1 and CYP1A1 genes.
    Han W; Pentecost BT; Spivack SD
    Mol Carcinog; 2003 Jul; 37(3):158-69. PubMed ID: 12884367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
    Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
    Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.